scholarly journals The risk factors of Chronic Kidney Disease in type 2 Diabetes Mellitus

2018 ◽  
Vol 9 (1) ◽  
pp. 19-24
Author(s):  
Manaor Napitupulu ◽  
Melita Aditya Sari ◽  
Sara Sonnya Ayutthaya
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Blood Glucose ◽  
Kidney Disease ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Dm ◽  
Initial Blood

Latar belakang: Penderita Diabetes melitus (DM) yang tidak ditangani dengan baik akan menimbulkankomplikasi Nefropati Diabetika sebagai penyebab utama dari Gagal Ginjal terminal. Tujuan penelitian iniadalah untuk menentukan faktor risiko Gagal Ginjal pada pasien DM tipe 2. Metode: Desain penelitian ini adalah potong lintang yang meneliti faktor risiko Gagal Ginjal pada pasienrawat jalan DM tipe 2 di bagian penyakit dalam RSUD kota Bekasi mulai tanggal 01 September 2015sampai dengan 30 September 2015. Data primer dikumpulkan melalui kuesioner terstruktur. Sampeldalam penelitian ini berjumlah 246 purposive individual sampling (107 pria dan 139 wanita). Analisisdata mempergunakan SPSS versi 21 dan EPISTAT versi 3.3 Hasil: Faktor risiko gagal ginjal yang terkait dengan perjalanan penyakit DM tipe 2 adalah: umur saatdidiagnosis DM 36-54 tahun (ORa=2.41; p=0.01); menderita DM 6-10 tahun dan lebih dari 10 tahunsetelah didiagnosis (ORa=4.30; p=0.000 vs ORa=18.54; p=0.000). Dibandingkan dengan kadar glukosadarah awal 201-300 mg/dl, responden dengan kadar gula darah awal 401-500 mg/dl dan lebih dari 500mg/dl masing-masing berisiko Gagal Ginjal 5.63 kali dan 11.11 kali (p=0.000 vs p=0.000). Kadar glukosadarah tertinggi >500 mg/dl berisiko Gagal Ginjal 5.86 kali dibandingkan dengan 201-300 mg/dl (p=0.000). Kesimpulan: Usia pada saat didiagnosis DM, lamanya menderita DM setelah didiagnosis, kadar glukosadarah awal dan kadar glukosa darah tertinggi >500 mg/dl merupakan faktor-faktor risiko Gagal Ginjal Kata kunci: Faktor risiko, progresi DM tipe 2, Gagal Ginjal AbstractBackground: A condition when Diabetes Mellitus patients does not get an adequate medical treatment,will cause Diabetic Nephropathy, which is a major cause of a terminal Chronic Kidney Disease (CKD).The objective of this study is to determine risk factors of CKD in patients with type 2 DM. Methods: Design of this study was a cross sectional, that investigated risk factors of CKD in outpatientswho suffered type 2 DM at Department of Internal Medicine of Bekasi General Hospital from the 1st ofSeptember to the 30th of September, 2015. Primary data was collected through structured questionnaires.Sample in this study was 246 purposive individual sampling (107 male and 139 female). The data analysisused SPSS version 21 and EPISTAT version 3.3. Results: The risk factors of CKD related to progressive of Diabetes Mellitus type 2 disease were: age atfirst diagnosed of DM 36-54 years (ORa=2.41; p=0.01), suffering DM 6-10 years and more than 10 yearsafter being diagnosed (ORa=4.30; p=0.000 vs ORa= 18.54; p=0.000 ). Referring to initial blood glucoselevels of 201-300 mg/dl, the respondents with initial blood glucose levels of 401-500 mg/dl and more than500 mg/dl had the risk of CKD 5.63 times and 11.11 times respectively (p=0.000 vs p=0.000). The highestblood glucose levels >500 mg/dl had the risk of CKD 5.86 times compared with 201-300 mg/dl (p=0.000). Conclusion: Age at first diagnosed of DM, duration of suffering DM post diagnosed, initial blood glucoselevels, and the highest blood glucose levels >500 mg/dl were the risk factors of CKD. Keywords: Risk factors, progressive of type 2 DM, CKD

scholarly journals Uji Efektivitas Beras Herbal Forte terhadap Penurunan Kadar Glukosa Darah Pasien Diabetes Melitus Tipe 2 (Study of the Herbal Rice Forte Effectiveness on Decreasing Blood Glucose of Diabetes Mellitus Type 2 Patient)

2018 ◽  
Vol 6 (1) ◽  
pp. 85
Author(s):  
Gema Akbar Wakhidana ◽  
Ancah Caesarina Novi Marchianti ◽  
Ali Santosa
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Treatment Group ◽  
Metabolic Diseases ◽  
Fasting Blood Glucose ◽  
Control Group ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Dm

Diabetes mellitus is metabolic diseases characterized by hyperglycemia caused by disturbances in insulin secretion or insulin activity. Herbal Forte Rice is rice synthetic material composed of main purple sweet potato and corn flour. It contains antioksidan, fiber, resistant starch and having moderate glycemic index. This study aimed to determine the effectivity of Herbal Forte Rice on decreasing blood glucose levels of patients type 2 DM. It used a cross-over design, the role of research subjects was both as control and treatment groups. Total sample of this research consisted of 60 samples. The treatment group was given Herbal Forte Rice for 7 days in 2 consecutive meals, while the control group did not receive any intervention. The results showed the average level of Fasting Blood Glucose (FBG) beginning and end of the treatment group 179.76 mg/dL and 138.7 mg/dL; FBG beginning and end of the control 180.87 mg/dL and 187.63 mg/dL; 2 hours post prandial Blood Glucose (2hppBG) levels of beginning and end of the treatment group 284.37 mg/dL and 183.8 mg/dL; 2hppBG levels beginning and end of the control 280.57 mg/dL and 284.13 mg/dL. This study concludes that Herbal Forte Rice effective on decreasing blood glucose levels of patients type 2 DM.   Keywords: diabetes mellitus, Rice Herbal Forte, GDP and GD2PP  

scholarly journals Effects of Blood Sugar Levels, Kidney Disease and Medication on Anaemia Status of Type 2 Diabetes Mellitus Patients

2020 ◽  
Author(s):  
Malala Mulavu ◽  
Mildred Zulu ◽  
Musalula Sinkala ◽  
Sody Munsaka ◽  
Pauline Okuku ◽  
...  
Keyword(s):  
Public Health ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Kidney Disease ◽  
Kidney Function ◽  
Glucose Levels ◽  
Blood Glucose Levels

ABSTRACTIntroductionLifestyle-related diseases like type 2 diabetes mellitus, have emerged as a significant public health problem due to rapid urbanization and industrialization. In 2018, the prevalence of type 2 diabetes mellitus was estimated to be 500 million cases worldwide and was comparable between high- and low-income countries. Diabetes leads to multiple complications, including end-stage renal disease, cardiovascular disease, infection, and death. Anaemia in diabetic individuals has severe adverse effects on the quality of life and is associated with disease progression. A cross-sectional study was conducted that included 101 participants. The study aimed to determine the prevalence of anaemia and kidney disease and their interplay with medication and/or blood glucose levels in T2D patients.Resultsseventy-one per cent of participants were females. Majority of patients 62% were on Insulin, 30% on metformin, 7% on a combination of metformin and glimepiride and 1% on glimepiride. Ninety-five (94%) of the participants were HIV negative. The prevalence of anaemia among the participants was 23% out of which 56% had moderate anaemia, and 44% had mild anaemia. Twenty-one per cent (21%) of the participants had high creatinine levels signifying impaired kidney function or kidney disease. Anaemia was significantly associated with kidney function, fasting blood glucose and use of metformin; p = 0.042 beta = 2.5, p = 0.025 beta = 2.7 and p = 0.040 beta = −2.5 respectively.ConclusionThe study found the prevalence of anaemia of 23%, which was of moderate public health concern. Also, the prevalence of kidney disease was high in patients with Type 2 Diabetes Mellitus. It also found that kidney disease and high blood glucose levels increase the chances of developing anaemia. However, we found that metformin had a protective role against the development of anaemia in Type 2 Diabetes Mellitus patients.

scholarly journals EVALUATION OF THE EFFECT OF TASTE GOOD BISCUITS ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

2021 ◽  
pp. 1-3
Author(s):  
Shobha JC ◽  
Rao PV
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Control Period ◽  
Glucose Variability ◽  
Target Range ◽  
Active Period ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Dm

BACKGROUND: Momordica charantia is widely used in the traditional medicine to manage patients with type 2 Diabetes Mellitus(DM). OBJECTIVE: To evaluate the effect of Taste Good biscuits (TGB) on blood glucose levels in patients with type 2 DM using CGMS. MATERIALS AND METHODS: This was an open label, controlled, non-randomized, prospective study. Total duration of study was for 14 days, 1-7 days of control period without TGB and 8-14 days of active period with TGB. During the control period regular antidiabetic treatment was continued, however during the active period, two TGB were consumed at 11am and at 4pm along with their regular anti diabetic treatment. Continuous glucose monitoring system (CGMS) was used to detect the fluctuations in the blood glucose levels during the entire study period. RESULTS: 62 type 2 DM patients participated in the study, 3 were lost to follow up. 39 were males and 20 females. There was statistically significant reduction in the mean glucose values during the active period with TGB as compared to the control period without TGB (p< 0.001). The glucose variability between the minimum and maximum glucose during the control period was statistically significantly more as compared to active period ( p <0.01). The glucose levels were in the target range of (80-140mg/dl) during the active period as compared to the control period (p< 0.001). However, the glucose levels were above the target range during the control period as compared to the active period (p < 0.001). CONCLUSION: TGB reduced the glucose variability in patients with type 2DM, hence TGB can be used as an adjuvant with regular antidiabetic medications.

scholarly journals Profil penggunaan obat antidiabetes pada pasien diabetes mellitus tipe 2 di instalasi rawat jalan RSUD Provinsi NTB tahun 2018

2021 ◽  
Vol 2 (1) ◽  
pp. 37-41
Author(s):  
Baiq Sofianti Annisa ◽  
Candra Eka Puspitasari ◽  
Siti Rahmatul Aini
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Fasting Blood Glucose ◽  
Regular Insulin ◽  
Cross Sectional ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Dm ◽  
Aspart Insulin

Diabetes mellitus (DM) is a disorder of insulin secretion, insulin action or both, which are characterized by blood glucose levels 200 mg/dl and / or fasting blood glucose levels 126 mg/dl. In 2017 Indonesia was recorded as the sixth largest country with DM in the world. The most common classification of diabetes is type 2 DM with an incidence 90-95%. The study aimed to determine the profile of antidiabetic use in type 2 DM patients at the outpatient installation of RSUD Provinsi NTB in 2018. This study used cross sectional design retrospectively with purposive sampling method for the period January-December 2018. The results showed that in 112 patients, 195 antidiabetic agents were prescribed. The antidiabetic prescribed were metformin (33.85%), glimepirid (25.13%), aspart insulin (13.33%), insulin detemir (8.21%), pioglitazone (6.67%), insulin glargine (6.67%), glyclazide (1.54%), gliquidone (1.54%), acarbose (1.54), regular insulin (1.03%), and insulin lispro (0.51%). Overall, antidiabetic use was in accordance with the guideline recommendations. Further research is needed regarding the review of prescriptions and detailed indications in order to increase rationality of drug use, reduce morbidity and mortality and reduce medical costs.

scholarly journals Glucose Levels During Gestational Diabetes Pregnancy and the Risk of Developing Postpartum Diabetes or Prediabetes

2020 ◽  
Author(s):  
Chadakarn Phaloprakarn ◽  
Siriwan Tangjitgamol
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Glycemic Control ◽  
Gestational Diabetes ◽  
Confidence Interval ◽  
Control Group ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Dm

Abstract Background: Blood glucose levels during pregnancy may reflect the severity of insulin secretory defects and/or insulin resistance during gestational diabetes mellitus (GDM) pregnancy. We hypothesized that suboptimal glycemic control in women with GDM could increase the risk of postpartum type 2 diabetes mellitus (DM) or prediabetes. Our objective was to evaluate the impact of plasma glucose levels throughout GDM pregnancy on the risk of postpartum type 2 DM or prediabetes. Methods: The medical records of 706 women with GDM who underwent a postpartum 75-g oral glucose tolerance test at our institution between January 2011 and December 2018 were reviewed. These women were classified into 2 groups according to glycemic control during pregnancy: ≤ 1 occasion of either fasting glucose ≥ 95 mg/dL or 2-h postprandial glucose ≥ 120 mg/dL was defined as optimal glycemic control or else was classified as suboptimal glycemic control. Rates of postpartum type 2 DM and prediabetes were compared between women with optimal (n = 505) and suboptimal (n = 201) glycemic control. Results: The rates of postpartum type 2 DM and prediabetes were significantly higher in the suboptimal glycemic control group than in the optimal glycemic control group: 22.4% vs. 3.0%, P < 0.001 for DM and 45.3% vs. 23.6%, P < 0.001 for prediabetes. In a multivariate analysis, suboptimal glucose control during pregnancy was an independent risk factor for developing either postpartum type 2 DM or prediabetes. The adjusted odds ratios were 18.9 (95% confidence interval, 7.0–50.7) for DM and 4.1 (95% confidence interval, 2.6–6.4) for prediabetes. Conclusion: Our findings suggest that blood glucose levels during GDM pregnancy have an impact on the risk of postpartum type 2 DM and prediabetes.

Efeitos dos Programas de Treinamento Aeróbio, de Força e Combinado na Glicose Sanguínea em Diabéticos do Tipo 2: uma Revisão Sistemática/ Effects of Aerobic, Strength and Combined Programs Training on Blood Glucose in Type 2 Diabetic: a Systematic Review.

1970 ◽  
Vol 5 (1) ◽  
pp. 61-74 ◽  
Author(s):  
Alexandre de Souza E Silva ◽  
Maria Paula Gonçalves Mota
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Training Program ◽  
Aerobic Training ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Pubmed Database

O trabalho tem como objetivo analisar os estudos que avaliaram os efeitos dos programas de treinamento aeróbio, força e combinado nos níveis de glicose sanguínea em indivíduos com diabetes do tipo 2. Foi utilizado o método de revisão sistemática, sendo utilizada a base de dados PubMed. As palavras chaves utilizadas para pesquisa foram training and diabetes. Foram identificados 484 artigos originais. Apenas 17 estudos respeitaram os critérios de inclusão. Os resultados evidenciam que os programas de treinamento aeróbio diminuíram os níveis de glicose. O programa de treinamento de força também foi favorável à diminuição dos níveis de glicose sanguínea. Já o programa de treinamento combinado não demonstrou efeitos favoráveis no controle da glicose sanguínea. Conclui-se que o programa de treinamento aeróbio e de força ajudam a controlar os níveis de glicose sanguínea em indivíduos com diabetes do tipo 2. Palavras-chave: diabetes mellitus, treinamento, glicose.ABSTRACTThe study aims to analyze the studies that evaluated the effects of aerobic, strength and combined programs training in blood glucose levels in people with type 2 diabetes. We used a systematic review method and is used to PubMed database. The key words used for searching were training and diabetes. We identified 484 original articles. Only 17 studies complied with the inclusion criteria. The results show that aerobic training programs decreased glucose levels. The strength training program was also favorable to decrease in blood glucose levels. But the combined training program has not shown favorable effects on blood glucose control. We conclude that the aerobic training and strength helps control blood glucose levels in individuals with type 2 diabetes. Keywords: diabetes mellitus, training, glucose.

scholarly journals Pharmaceutical hit of anti type 2 Diabetes mellitus on the phenolic extract of Malaka (Phyllanthus emblica L.) flesh

2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Musri Musman ◽  
Mauli Zakia ◽  
Ratu Fazlia Inda Rahmayani ◽  
Erlidawati Erlidawati ◽  
Safrida Safrida
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Body Weight ◽  
Blood Glucose ◽  
Phyllanthus Emblica ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Phenolic Extract

Abstract Background Ethnobotany knowledge in a community has shaped local wisdom in utilizing plants to treat diseases, such as the use of Malaka (Phyllanthus emblica) flesh to treat type 2 diabetes. This study presented evidence that the phenolic extract of the Malaka flesh could reduce blood sugar levels in the diabetic induced rats. Methods The phenolic extract of the P. emblica was administrated to the glucose-induced rats of the Wistar strain Rattus norvegicus for 14 days of treatment where the Metformin was used as a positive control. The data generated were analyzed by the two-way ANOVA Software related to the blood glucose level and by SAS Software related to the histopathological studies at a significant 95% confidence. Results The phenolic extract with concentrations of 100 and 200 mg/kg body weight could reduce blood glucose levels in diabetic rats. The post hoc Dunnet test showed that the administration of the extract to the rats with a concentration of 100 mg/kg body weight demonstrated a very significant decrease in blood glucose levels and repaired damaged cells better than administering the extract at a concentration of 200 mg/kg weight body. Conclusion The evidence indicated that the phenolic extract of the Malaka flesh can be utilized as anti type 2 Diabetes mellitus without damaging other organs.

scholarly journals Study on the prevalence of dyslipidemia in type 2 diabetes mellitus

2019 ◽  
Vol 6 (3) ◽  
pp. 786
Author(s):  
Eda Dayakar ◽  
C. Sathya Sree ◽  
E. Sanjay
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Diabetic Patients ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Diabetic

Background: Diabetes mellitus is a common health problem globally. Dyslipidaemia is a major risk factor to develop cardiovascular disease in diabetics. They present study was undertaken to find out the prevalence of dyslipidaemia in type 2 diabetic patients.Methods: The present study was a cross sectional study consisting of 46 (23 male and 23 female) known type 2 diabetes mellitus patients. Age, gender, duration of diabetes, body mass index (BMI) was recorder in all the diabetic patients.  Fasting blood glucose levels, total cholesterol, triglycerides, HDL, LDL, VLDL levels were measured using standard methods and recorded.Results: The average total cholesterol, triglycerides, LDL, HDL and VLDL were 200±42mg/dl, 169.62±89.79mg/dl, 132.45±36.38mg/dl,39.1±16.6mg/dl and 35.85±17.09mg/dl respectively. The incidence of occurrence of hypercholesterolemia was 58.6% and hypertriglyceridemia 36.9%. Increased levels of LDL were observed in 30 (65.2%) patients and reduced HDL was observed in 43 (93.4%) patients. The incidence rate of dyslipidaemia was higher in female diabetic patients when compared to male diabetic patients.Conclusions: Awareness on the dyslipidaemia and its risk factors should be provided to the type 2 diabetic patients as they are more prone to get cardiovascular disease and lipid profile also should be monitored regularly along with blood glucose levels.

Sign in / Sign up

Export Citation Format

Share Document